November 10, 2025 · Form 4 insider transaction
Lawver Teri L bought 100,000 shares of Celldex Therapeutics ADR at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.; 25% vest on November 10, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.